Cargando…
Altered immunoreactivity of ErbB4, a causative gene product for ALS19, in the spinal cord of patients with sporadic ALS
ErbB4 is the protein implicated in familial amyotrophic lateral sclerosis (ALS), designated as ALS19. ErbB4 is a receptor tyrosine kinase activated by its ligands, neuregulins (NRG), and plays an essential role in the function and viability of motor neurons. Mutations in the ALS19 gene lead to the r...
Autores principales: | Takahashi, Yuji, Uchino, Akiko, Shioya, Ayako, Sano, Terunori, Matsumoto, Chihiro, Numata‐Uematsu, Yurika, Nagano, Seiichi, Araki, Toshiyuki, Murayama, Shigeo, Saito, Yuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852233/ https://www.ncbi.nlm.nih.gov/pubmed/31124187 http://dx.doi.org/10.1111/neup.12558 |
Ejemplares similares
-
Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
por: Li, Guangyuan, et al.
Publicado: (2014) -
Association of Elevated Expression of the c‐erbB‐2 Protein with Spread of Breast Cancer
por: Yamada, Yukinori, et al.
Publicado: (1989) -
An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer.
por: Walker, R. A., et al.
Publicado: (1989) -
ErbB2 Receptor Immunoreactivity in Prostate Cancer: Relationship to the Androgen Receptor, Disease Severity at Diagnosis and Disease Outcome
por: Hammarsten, Peter, et al.
Publicado: (2014) -
Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4
por: Sutherland, Robert L
Publicado: (2011)